Stocks Health care NGEN
NASDAQ · Health careNervgen Pharma Corp. (NGEN)
It posted a net loss of CA$44.1M. At December 31, 2025 it held CA$22.1M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (amended) (40-F/A) filed on October 16, 2026.
Key facts about Nervgen Pharma Corp.
- Net worth
- Nervgen Pharma Corp. has a market value (market cap) of $141.5M at the latest share price, and shareholders' equity of CA$3.5M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used CA$19.5M of cash.
- Latest report
- The latest periodic report (annual report (Canadian issuer) (amended), 40-F/A) was filed with the SEC on October 16, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Nervgen Pharma Corp. does
Nervgen Pharma Corp. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NGEN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -CA$44.1M | -CA$0.61 | n/a |
| 2025 | n/a | -CA$24.3M | -CA$0.36 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Nervgen Pharma Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 16, 2026
- October 16, 2026Annual report (Canadian issuer) (amended) 40-F/A · period to December 31, 2025Diluted EPS -0.61 CAD versus -0.36 CAD.
- September 25, 2026
- September 24, 2026
- August 13, 2026
- July 2, 2026
- July 2, 2026Form SUPPL filing SUPPL
- June 1, 2026
- May 26, 2026
- May 26, 2026Form SUPPL filing SUPPL
Insider trades
What the people running Nervgen Pharma Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about NGEN
What does Nervgen Pharma Corp. do?
Nervgen Pharma Corp. is a company in the Health care sector, listed on NASDAQ as NGEN. Its shares trade on NASDAQ under the ticker NGEN.
What is Nervgen Pharma Corp.'s net worth?
Nervgen Pharma Corp. has a market value (market cap) of $141.5M at the latest share price, and shareholders' equity of CA$3.5M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Nervgen Pharma Corp. profitable?
No. In fiscal 2025 it reported a net loss of CA$44.1M.
When did Nervgen Pharma Corp. last report?
Its most recent periodic report is the annual report (Canadian issuer) (amended) (40-F/A) filed on October 16, 2026. It covers the period to December 31, 2025.
Similar companies
Compare NGEN with
Follow NGEN
Get an email when Nervgen Pharma Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Nervgen Pharma Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.